Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
Wuhan, China, in December 2019 and has spread globally with sustained human-to-human …

Understanding the particle size distribution in the air and patterns of environmental contamination
of SARS-CoV-2 is essential for infection prevention policies. Here we screen surface …

Objectives Highly effective vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) have been developed but variants of concerns are worrisome, especially B.…

The coronavirus disease 2019 (COVID-19) pandemic spread globally in the beginning of
2020. At present, predictors of severe disease and the efficacy of different treatments are not …

Given the ongoing SARS-CoV-2 pandemic, identification of immunogenic targets against
the coronavirus spike glycoprotein will provide crucial advances towards the development of …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread rapidly across
the globe to cause a pandemic. Although it is known to be transmitted via droplets, …

Background Studies have found different waning rates of neutralising antibodies compared
with binding antibodies against SARS-CoV-2. The impact of neutralising antibody waning …

Background The impact of SARS-CoV-2 variants of concern (VOCs) on disease severity is
unclear. In this retrospective study, we compared the outcomes of patients infected with B.1.1.7…

Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical
COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in …

Coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus 2,
has been declared a pandemic by the World Health Organization. As the pandemic evolves …